Opportunities and Challenges for AI-Based Analysis of RWD in Pharmaceutical R&D: A Practical Perspective

URN to cite this document:: urn:nbn:de:bvb:355-epub-548086
DOI to cite this document:: 10.5283/epub.54808

Behr, Merle

; Burghaus, Rolf ; Diedrich, Christian ; Lippert, Jörg

License: Creative Commons Attribution 4.0
PDF - Published Version
(695kB)

Date of publication of this fulltext: 17 Oct 2023 05:35

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Springer.

Details

Preview

Export bibliographical data

Abstract

Real world data (RWD) has become an important tool in pharmaceutical research and development. Generated every time patients interact with the healthcare system when diagnoses are developed and medical interventions are selected, RWD are massive and in many regards typical big data. The use of artificial intelligence (AI) to analyze RWD seems an obvious choice. It promises new insights into ...